Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2316
Gene Symbol: FLNA
FLNA
0.010 GeneticVariation group BEFREE Cardiac defects can be the presenting symptom in patients with mutations in the X-linked gene FLNA. 20730588 2011
Entrez Id: 2626
Gene Symbol: GATA4
GATA4
0.070 GeneticVariation group BEFREE Cardiac defects are infrequent findings in individuals with 8p23.1 genomic duplications containing GATA4. 21933911 2011
Entrez Id: 2066
Gene Symbol: ERBB4
ERBB4
0.010 Biomarker group BEFREE ErbB4-deleted lungs of 11- to 14-wk-old adult HER4heart mice, rescued from their lethal cardiac defects, were studied for the effect on lung function, alveolarization, and the surfactant system. 18203811 2008
Entrez Id: 10370
Gene Symbol: CITED2
CITED2
0.030 GeneticVariation group BEFREE CITED2 mutations lead to a constellation of cardiac defects, which include tetralogy of Fallot and outflow tract malformations. 22735262 2012
Entrez Id: 406960
Gene Symbol: MIR184
MIR184
0.010 AlteredExpression group BEFREE MiR-184 was significantly down-regulated in CHD patients with cyanotic cardiac defects. 26823736 2015
Entrez Id: 6943
Gene Symbol: TCF21
TCF21
0.010 Biomarker group BEFREE TCF21 knockout mice display cardiac defects, including ventricular septal defects (VSDs). 28346832 2017
Entrez Id: 2626
Gene Symbol: GATA4
GATA4
0.070 Biomarker group BEFREE GATA4, a protein related to osteoblast differentiation and mineralization, whose acetylation is essential for cardiac defects. 29590644 2018
Entrez Id: 6899
Gene Symbol: TBX1
TBX1
0.050 Biomarker group BEFREE CATCH 22 is an acronym for cardiac defect, abnormal facies, thymic hypoplasia or aplasia and T-cell deficiency, cleft palate, hypoparathyroidism, and hypocalcemia. 9099830 1997
Entrez Id: 1714
Gene Symbol: DGCR
DGCR
0.040 Biomarker group BEFREE CATCH 22 is an acronym for cardiac defect, abnormal facies, thymic hypoplasia or aplasia and T-cell deficiency, cleft palate, hypoparathyroidism, and hypocalcemia. 9099830 1997
Entrez Id: 4313
Gene Symbol: MMP2
MMP2
0.010 GeneticVariation group BEFREE A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects. 18985071 2009
Entrez Id: 3263
Gene Symbol: HPX
HPX
0.010 GeneticVariation group BEFREE A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects. 18985071 2009
Entrez Id: 83595
Gene Symbol: SOX7
SOX7
0.010 GeneticVariation group BEFREE A potential relationship among beta-defensins haplotype, SOX7 duplication and cardiac defects. 24009689 2013
Entrez Id: 8216
Gene Symbol: LZTR1
LZTR1
0.010 GeneticVariation group BEFREE All probands with LZTR1 variants had cardiac defects, including hypertrophic cardiomyopathy and atrial septal defect. 30368668 2019
Entrez Id: 2626
Gene Symbol: GATA4
GATA4
0.070 Biomarker group BEFREE Although GATA4-deficient mice have both CDH and cardiac defects, no humans with cardiac defects attributed to GATA4 mutations have been reported to have CDH. 22723016 2012
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.010 Biomarker group BEFREE Children with 22q11.2DS without cardiac defects show smaller LPA compared with healthy subjects. 30933971 2019
Entrez Id: 4628
Gene Symbol: MYH10
MYH10
0.010 GeneticVariation group BEFREE Complementation testing confirmed that the Myh10 mutation causes the EHC phenotype. 29084269 2017
Entrez Id: 26164
Gene Symbol: MTG2
MTG2
0.010 Biomarker group BEFREE De novo deletion of chromosome 20q13.33 in a patient with tracheo-esophageal fistula, cardiac defects and genitourinary anomalies implicates GTPBP5 as a candidate gene. 21608104 2011
Entrez Id: 84910
Gene Symbol: TMEM87B
TMEM87B
0.010 Biomarker group BEFREE Depletion of both fibulin-7B and TMEM87B resulted in more severe defects of cardiac development, suggesting that their concurrent loss may enhance the risk of a severe cardiac defect. 24694933 2014
Entrez Id: 6899
Gene Symbol: TBX1
TBX1
0.050 Biomarker group BEFREE DiGeorge (DGS, MIM 188400) and velocardiofacial (VCFS, MIM 192430) syndromes may present many clinical problems including cardiac defects, hypoparathyroidism, T-cell immunodeficiency and facial dysmorphism. 8696341 1996
Entrez Id: 1714
Gene Symbol: DGCR
DGCR
0.040 Biomarker group BEFREE DiGeorge (DGS, MIM 188400) and velocardiofacial (VCFS, MIM 192430) syndromes may present many clinical problems including cardiac defects, hypoparathyroidism, T-cell immunodeficiency and facial dysmorphism. 8696341 1996
Entrez Id: 8862
Gene Symbol: APLN
APLN
0.010 GeneticVariation group BEFREE Double-mutant analyses showed that loss of Apela signaling impacts early Aplnr-expressing mesodermal populations independently of the alternative ligand Apelin, leading to lethal cardiac defects in some Apela null embryos. 28854362 2017
Entrez Id: 5781
Gene Symbol: PTPN11
PTPN11
0.020 AlteredExpression group BEFREE Expression of Noonan or LEOPARD Shp2 phenocopied the craniofacial and cardiac defects of human patients. 18159945 2007
Entrez Id: 1482
Gene Symbol: NKX2-5
NKX2-5
0.010 GeneticVariation group BEFREE Fruit flies lacking the gene (tinman) fail to form a dorsal vessel, mice that are homozygous null for Nkx2-5 form small, deformed hearts, and several human cardiac defects have been linked to dominant mutations in the Nkx2-5 gene. 17685485 2007
Entrez Id: 867
Gene Symbol: CBL
CBL
0.010 GeneticVariation group BEFREE Genotype-phenotype correlation analysis performed on available records indicated that germline CBL mutations cause a variable phenotype characterized by a relatively high frequency of neurological features, predisposition to juvenile myelomonocytic leukemia, and low prevalence of cardiac defects, reduced growth, and cryptorchidism. 25952305 2015
Entrez Id: 4212
Gene Symbol: MEIS2
MEIS2
0.310 Biomarker group GENOMICS_ENGLAND Haploinsufficiency of MEIS2 is associated with orofacial clefting and learning disability. 24678003 2014